| A rapid bead-based radioligand binding assay for the determination of target-binding fraction and quality control of radiopharmaceuticals SK Sharma, SK Lyashchenko, HA Park, N Pillarsetty, Y Roux, J Wu, ... Nuclear medicine and biology 71, 32-38, 2019 | 52 | 2019 |
| Bioorthogonal masking of circulating antibody–TCO groups using tetrazine-functionalized dextran polymers JP Meyer, KM Tully, J Jackson, TR Dilling, T Reiner, JS Lewis Bioconjugate chemistry 29 (2), 538-545, 2018 | 46 | 2018 |
| An in Vivo Nanosensor Measures Compartmental Doxorubicin Exposure JD Harvey, RM Williams, KM Tully, HA Baker, Y Shamay, DA Heller Nano letters 19 (7), 4343-4354, 2019 | 39 | 2019 |
| Toward the optimization of click-mediated pretargeted radioimmunotherapy R Membreno, OM Keinänen, BE Cook, KM Tully, KC Fung, JS Lewis, ... Molecular pharmaceutics 16 (5), 2259-2263, 2019 | 28 | 2019 |
| Radioimmunotherapy targeting delta-like ligand 3 in small cell lung cancer exhibits antitumor efficacy with low toxicity KM Tully, S Tendler, LM Carter, SK Sharma, ZV Samuels, K Mandleywala, ... Clinical Cancer Research 28 (7), 1391-1401, 2022 | 24 | 2022 |
| Delta-like ligand 3–targeted radioimmunotherapy for neuroendocrine prostate cancer JA Korsen, JA Gutierrez, KM Tully, LM Carter, ZV Samuels, S Khitrov, ... Proceedings of the National Academy of Sciences 119 (27), e2203820119, 2022 | 19 | 2022 |
| Electrostatic screening modulates analyte binding and emission of carbon nanotubes JD Harvey, GH Zerze, KM Tully, J Mittal, DA Heller The Journal of Physical Chemistry C 122 (19), 10592-10599, 2018 | 15 | 2018 |
| Caveolin-1 temporal modulation enhances antibody drug efficacy in heterogeneous gastric cancer PMR Pereira, K Mandleywala, S Monette, M Lumish, KM Tully, SS Panikar, ... Nature communications 13 (1), 2526, 2022 | 14 | 2022 |
| Improved synthesis of the bifunctional chelator p-SCN-Bn-HOPO NVSDK Bhupathiraju, A Younes, M Cao, J Ali, HT Cicek, KM Tully, ... Organic & biomolecular chemistry 17 (28), 6866-6871, 2019 | 13 | 2019 |
| Molecular Imaging Companion Diagnostics KM Tully, NB Sobol, PMR Pereira, JS Lewis Companion and complementary diagnostics, 201-228, 2019 | 5 | 2019 |
| Antibody-Based Molecular Imaging KM Tully, VL Nagle, JA Korsen, JS Lewis Molecular Imaging, 547-562, 2021 | 1 | 2021 |
| Caveolin-1 temporal modulation enhances trastuzumab and trastuzumab-drug conjugate efficacy in heterogeneous gastric cancer PMR Pereira, K Mandleywala, S Monette, M Lumish, KM Tully, M Cornejo, ... bioRxiv, 2021.07. 13.452260, 2021 | | 2021 |
| Radioimmunotherapy and ImmunoPET Imaging Targeting Delta-like Ligand 3 in Small Cell Lung Cancer KM Tully Weill Medical College of Cornell University, 2021 | | 2021 |
| Evaluating HOPO chelators with therapeutic radioisotopes for theranostic applications in immunoPET imaging and radioimmunotherapy K Tully, D Demoin, M Deri, J Hatcher, L Francesconi, J Lewis Nuclear Medicine and Biology 72, S49, 2019 | | 2019 |
| The optimization of click-mediated pretargeted radioimmunotherapy R Membreno, B Cook, K Tully, J Lewis, B Zeglis Nuclear Medicine and Biology 72, S17-S18, 2019 | | 2019 |
| A Rapid Bead Based Radioimmunoassay for the Determination of Target Binding Fraction and Quality Control of Radiopharmaceuticals SK Sharma, S Lyashchenko, H Park, Y Roux, NVK Pillarsetty, S Poty, ... Journal of Nuclear Medicine 60 (supplement 1), 132-132, 2019 | | 2019 |
